Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP831858.RAhc2RwmWXVO58LIbFOG9la3TfN9hqSwswERqhvwmuUfE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP831858.RAhc2RwmWXVO58LIbFOG9la3TfN9hqSwswERqhvwmuUfE130_assertion type Assertion NP831858.RAhc2RwmWXVO58LIbFOG9la3TfN9hqSwswERqhvwmuUfE130_head.
- NP831858.RAhc2RwmWXVO58LIbFOG9la3TfN9hqSwswERqhvwmuUfE130_assertion description "[ABL mutations are common in Chinese imatinib-resistant CML patients and are associated with clinical resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP831858.RAhc2RwmWXVO58LIbFOG9la3TfN9hqSwswERqhvwmuUfE130_provenance.
- NP831858.RAhc2RwmWXVO58LIbFOG9la3TfN9hqSwswERqhvwmuUfE130_assertion evidence source_evidence_literature NP831858.RAhc2RwmWXVO58LIbFOG9la3TfN9hqSwswERqhvwmuUfE130_provenance.
- NP831858.RAhc2RwmWXVO58LIbFOG9la3TfN9hqSwswERqhvwmuUfE130_assertion SIO_000772 20697894 NP831858.RAhc2RwmWXVO58LIbFOG9la3TfN9hqSwswERqhvwmuUfE130_provenance.
- NP831858.RAhc2RwmWXVO58LIbFOG9la3TfN9hqSwswERqhvwmuUfE130_assertion wasDerivedFrom befree-2016 NP831858.RAhc2RwmWXVO58LIbFOG9la3TfN9hqSwswERqhvwmuUfE130_provenance.
- NP831858.RAhc2RwmWXVO58LIbFOG9la3TfN9hqSwswERqhvwmuUfE130_assertion wasGeneratedBy ECO_0000203 NP831858.RAhc2RwmWXVO58LIbFOG9la3TfN9hqSwswERqhvwmuUfE130_provenance.